<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Si-bone, Inc. — News on 6ix</title>
<link>https://6ix.com/company/si-bone-inc</link>
<description>Latest news and press releases for Si-bone, Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 11 May 2026 20:09:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/si-bone-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835c14978dffbe2df118d79.webp</url>
<title>Si-bone, Inc.</title>
<link>https://6ix.com/company/si-bone-inc</link>
</image>
<item>
<title>SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance</title>
<link>https://6ix.com/company/si-bone-inc/news/si-bone-inc-reports-financial-results-for-the-first-quarter-2026-and-raises-2026-guidance</link>
<guid isPermaLink="true">https://6ix.com/company/si-bone-inc/news/si-bone-inc-reports-financial-results-for-the-first-quarter-2026-and-raises-2026-guidance</guid>
<pubDate>Mon, 11 May 2026 20:09:00 GMT</pubDate>
<description>Delivered ~11% worldwide revenue growth, record physician engagement and ~440% improvement in adjusted EBITDAFirst Quarter 2026 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $52.6 million, representing growth of 11.2%U.S. revenue of $49.3 million, representing growth of 10.0%Gross margin of 79.8% Net loss of $4.3 million, representing an improvement of 33.8% Adjusted EBITDA of $2.5 million, representing an improvement of over 440%$144.7 million in cash</description>
</item>
<item>
<title>SI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026</title>
<link>https://6ix.com/company/si-bone-inc/news/si-bone-to-present-at-bofa-securities-2026-healthcare-conference-on-may-12-2026</link>
<guid isPermaLink="true">https://6ix.com/company/si-bone-inc/news/si-bone-to-present-at-bofa-securities-2026-healthcare-conference-on-may-12-2026</guid>
<pubDate>Thu, 30 Apr 2026 20:09:00 GMT</pubDate>
<description>SANTA CLARA, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced that the company will be participating in the upcoming 2026 BofA Securities Healthcare Conference in Las Vegas, NV. Management will be hosting a fireside chat on Tuesday, May 12, 2026, at 8:00 a.m. Pacific Time/11:00 a.m. Eastern Time. Investors interested in listening to the con</description>
</item>
<item>
<title>SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026</title>
<link>https://6ix.com/company/si-bone-inc/news/si-bone-to-report-first-quarter-2026-financial-results-on-may-11-2026</link>
<guid isPermaLink="true">https://6ix.com/company/si-bone-inc/news/si-bone-to-report-first-quarter-2026-financial-results-on-may-11-2026</guid>
<pubDate>Mon, 20 Apr 2026 20:09:00 GMT</pubDate>
<description>SANTA CLARA, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced it will report financial results for the first quarter of 2026 after market close on Monday, May 11, 2026. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time Investors interested in listening to the conference call may do so by reg</description>
</item>
<item>
<title>SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance</title>
<link>https://6ix.com/company/si-bone-inc/news/si-bone-inc-reports-record-financial-results-for-the-fourth-quarter-2025-and-issues-2026-guidance</link>
<guid isPermaLink="true">https://6ix.com/company/si-bone-inc/news/si-bone-inc-reports-record-financial-results-for-the-fourth-quarter-2025-and-issues-2026-guidance</guid>
<pubDate>Mon, 23 Feb 2026 21:09:00 GMT</pubDate>
<description>Achieves 20% worldwide revenue growth and positive adjusted EBITDA for Fiscal Year 2025Generates free cash flow in the Fourth Quarter 2025 SANTA CLARA, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights (all comparisons are t</description>
</item>
<item>
<title>SI-BONE To Present at TD Cowen 46th Annual Health Care Conference on March 2, 2026</title>
<link>https://6ix.com/company/si-bone-inc/news/si-bone-present-td-cowen-213000236</link>
<guid isPermaLink="true">https://6ix.com/company/si-bone-inc/news/si-bone-present-td-cowen-213000236</guid>
<pubDate>Tue, 17 Feb 2026 21:30:00 GMT</pubDate>
<description>SANTA CLARA, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced that the company will be participating in the upcoming TD Cowen 46th Annual Health Care Conference in Boston, MA. Management will be hosting a fireside chat on Monday, March 2, 2026, at 7:30 a.m. Pacific Time/ 10:30 a.m. Eastern Time. Investors interested in listening to the confe</description>
</item>
<item>
<title>SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026</title>
<link>https://6ix.com/company/si-bone-inc/news/si-bone-report-fourth-quarter-213000703</link>
<guid isPermaLink="true">https://6ix.com/company/si-bone-inc/news/si-bone-report-fourth-quarter-213000703</guid>
<pubDate>Mon, 02 Feb 2026 21:30:00 GMT</pubDate>
<description>SANTA CLARA, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced it will report financial results for the fourth quarter and full year ended December 31, 2025 after market close on Monday, February 23, 2026. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to</description>
</item>
<item>
<title>SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025</title>
<link>https://6ix.com/company/si-bone-inc/news/si-bone-announces-preliminary-revenue-fourth-quarter-and-full-year-2025-2026-01-12</link>
<guid isPermaLink="true">https://6ix.com/company/si-bone-inc/news/si-bone-announces-preliminary-revenue-fourth-quarter-and-full-year-2025-2026-01-12</guid>
<pubDate>Mon, 12 Jan 2026 05:00:00 GMT</pubDate>
<description>Fiscal Year 2025 worldwide revenue of $200.8 to $200.9 million, representing growth of ~20% SANTA CLARA, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- SI-BONE,</description>
</item>
<item>
<title>Galvanize Therapeutics Appoints Laura Francis to its Board of Directors</title>
<link>https://6ix.com/company/si-bone-inc/news/galvanize-therapeutics-appoints-laura-francis-to-its-board-of-directors-1</link>
<guid isPermaLink="true">https://6ix.com/company/si-bone-inc/news/galvanize-therapeutics-appoints-laura-francis-to-its-board-of-directors-1</guid>
<pubDate>Mon, 24 Nov 2025 12:00:00 GMT</pubDate>
<description>Galvanize ("Galvanize") Therapeutics, Inc., a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for oncology and chronic lung disease, today announced the appointment of Laura Francis to its Board of Directors.</description>
</item>
<item>
<title>SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025</title>
<link>https://6ix.com/company/si-bone-inc/news/si-bone-present-piper-sandler-37th-annual-healthcare-conference-december-2-2025-2025</link>
<guid isPermaLink="true">https://6ix.com/company/si-bone-inc/news/si-bone-present-piper-sandler-37th-annual-healthcare-conference-december-2-2025-2025</guid>
<pubDate>Tue, 18 Nov 2025 05:00:00 GMT</pubDate>
<description>SANTA CLARA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders,</description>
</item>
<item>
<title>SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance</title>
<link>https://6ix.com/company/si-bone-inc/news/si-bone-inc-reports-financial-results-third-quarter-2025-and-raises-2025-guidance</link>
<guid isPermaLink="true">https://6ix.com/company/si-bone-inc/news/si-bone-inc-reports-financial-results-third-quarter-2025-and-raises-2025-guidance</guid>
<pubDate>Mon, 10 Nov 2025 05:00:00 GMT</pubDate>
<description>Delivered ~21% worldwide revenue growth, ~5% adjusted EBITDA margin, and positive cash from operating activities in the quarter Third Quarter 2025 Financial</description>
</item>
<item>
<title>SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025</title>
<link>https://6ix.com/company/si-bone-inc/news/si-bone-report-third-quarter-2025-financial-results-november-10-2025-2025-10-20</link>
<guid isPermaLink="true">https://6ix.com/company/si-bone-inc/news/si-bone-report-third-quarter-2025-financial-results-november-10-2025-2025-10-20</guid>
<pubDate>Mon, 20 Oct 2025 04:00:00 GMT</pubDate>
<description>SANTA CLARA, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders,</description>
</item>
<item>
<title>SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025</title>
<link>https://6ix.com/company/si-bone-inc/news/si-bone-present-morgan-stanley-23rd-global-healthcare-conference-september-9-2025</link>
<guid isPermaLink="true">https://6ix.com/company/si-bone-inc/news/si-bone-present-morgan-stanley-23rd-global-healthcare-conference-september-9-2025</guid>
<pubDate>Tue, 26 Aug 2025 04:00:00 GMT</pubDate>
<description>SANTA CLARA, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders,</description>
</item>
<item>
<title>Synergy Spine Solutions Appoints Troy Wahlenmaier as Chief Commercial Officer</title>
<link>https://6ix.com/company/si-bone-inc/news/synergy-spine-solutions-appoints-troy-wahlenmaier-as-chief-commercial-officer</link>
<guid isPermaLink="true">https://6ix.com/company/si-bone-inc/news/synergy-spine-solutions-appoints-troy-wahlenmaier-as-chief-commercial-officer</guid>
<pubDate>Thu, 14 Aug 2025 17:22:00 GMT</pubDate>
<description>Synergy Spine Solutions Inc., a leading innovator in artificial cervical disc replacement, today announced the appointment of Troy Wahlenmaier as Chief Commercial Officer (CCO). In this role, Mr. Wahlenmaier will lead global sales and marketing efforts as the company accelerates its growth and prepares for U.S. commercialization.</description>
</item>
<item>
<title>SI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 Guidance</title>
<link>https://6ix.com/company/si-bone-inc/news/si-bone-inc-reports-financial-results-second-quarter-2025-and-raises-2025-guidance</link>
<guid isPermaLink="true">https://6ix.com/company/si-bone-inc/news/si-bone-inc-reports-financial-results-second-quarter-2025-and-raises-2025-guidance</guid>
<pubDate>Mon, 04 Aug 2025 04:00:00 GMT</pubDate>
<description>Achieved ~22% worldwide revenue growth, positive Adjusted EBITDA and cash flow breakeven Second Quarter 2025 Financial Highlights (all comparisons are to the</description>
</item>
<item>
<title>SI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025</title>
<link>https://6ix.com/company/si-bone-inc/news/si-bone-present-canaccord-genuity-45th-annual-growth-conference-august-12-2025-2025</link>
<guid isPermaLink="true">https://6ix.com/company/si-bone-inc/news/si-bone-present-canaccord-genuity-45th-annual-growth-conference-august-12-2025-2025</guid>
<pubDate>Tue, 29 Jul 2025 04:00:00 GMT</pubDate>
<description>SANTA CLARA, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders,</description>
</item>
<item>
<title>SI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025</title>
<link>https://6ix.com/company/si-bone-inc/news/si-bone-report-second-quarter-2025-financial-results-august-4-2025-2025-07-14</link>
<guid isPermaLink="true">https://6ix.com/company/si-bone-inc/news/si-bone-report-second-quarter-2025-financial-results-august-4-2025-2025-07-14</guid>
<pubDate>Mon, 14 Jul 2025 04:00:00 GMT</pubDate>
<description>SANTA CLARA, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders,</description>
</item>
<item>
<title>SI-BONE to Present at Truist Securities MedTech Conference on June 17, 2025</title>
<link>https://6ix.com/company/si-bone-inc/news/si-bone-present-truist-securities-203000214</link>
<guid isPermaLink="true">https://6ix.com/company/si-bone-inc/news/si-bone-present-truist-securities-203000214</guid>
<pubDate>Wed, 04 Jun 2025 20:30:00 GMT</pubDate>
<description>SANTA CLARA, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming 2025 Truist Securities MedTech Conference in Boston, MA. Management will be hosting a fireside chat on Tuesday, June 17, 2025, at 10:00 a.m. Pacific Time/1:00 p.m. Eastern Time. Investors interested in listening to the conference call may do so by registering at this link: T</description>
</item>
<item>
<title>SI-BONE to Truist Securities MedTech Conference on June 17, 2025</title>
<link>https://6ix.com/company/si-bone-inc/news/si-bone-truist-securities-medtech-conference-june-17-2025-2025-06-04</link>
<guid isPermaLink="true">https://6ix.com/company/si-bone-inc/news/si-bone-truist-securities-medtech-conference-june-17-2025-2025-06-04</guid>
<pubDate>Wed, 04 Jun 2025 04:00:00 GMT</pubDate>
<description>SANTA CLARA, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders,</description>
</item>
<item>
<title>SI-BONE to Present at Goldman Sachs 46th Global Healthcare Conference on June 10, 2025</title>
<link>https://6ix.com/company/si-bone-inc/news/si-bone-present-goldman-sachs-46th-global-healthcare-conference-june-10-2025-2025-05</link>
<guid isPermaLink="true">https://6ix.com/company/si-bone-inc/news/si-bone-present-goldman-sachs-46th-global-healthcare-conference-june-10-2025-2025-05</guid>
<pubDate>Wed, 28 May 2025 04:00:00 GMT</pubDate>
<description>SANTA CLARA, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today</description>
</item>
<item>
<title>SI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025</title>
<link>https://6ix.com/company/si-bone-inc/news/si-bone-present-bofa-securities-2025-healthcare-conference-may-13-2025-2025-05-06</link>
<guid isPermaLink="true">https://6ix.com/company/si-bone-inc/news/si-bone-present-bofa-securities-2025-healthcare-conference-may-13-2025-2025-05-06</guid>
<pubDate>Tue, 06 May 2025 04:00:00 GMT</pubDate>
<description>SANTA CLARA, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today</description>
</item>
</channel>
</rss>